Subjective Factors of Polymedication in the Elderly: a Qualitative Study of the Perceptions of Patients, Relatives and Referent Physicians.(DOSAGE)
NCT ID: NCT03309228
Last Updated: 2018-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2016-11-16
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Opposition to Diagnostic or Therapeutic Procedures by Aged Hospitalized Patient
NCT03373838
Requests for Euthanasia and Assisted Suicide in Establishment of Accommodation for Dependent Old Persons.
NCT03353870
Frailty Assessment and Treatment Strategies in the Elderly at Risk of Functional Decline in the Community
NCT03591055
Education for Prevention and Treatment of Frailty
NCT05610605
Loss of Autonomy in the Elderly: Relationships Between Gut Microbiota Diversity, Nutrition and Cognitive and Sensory-motor Disturbances in "Small Eaters" and "Non Small Eaters"
NCT05449119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Qualitative Research
Semi-structured interviews with patients, relatives and general practitioners.
individual interviews
Semi-structured individual interviews with patients, relatives and general practitioners.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
individual interviews
Semi-structured individual interviews with patients, relatives and general practitioners.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women aged 75 and over
* Beneficiary of a prescription of medicinal products fulfilling the conditions of major polymedication: to include 10 different drugs whatever the way of use (per os, subcutaneous, intravenous, intra muscular, cutaneous, instillation)
* Informed consent stating that the subject understood the purpose and methodology of the study and agrees to participate in the study.
* For the relatives:
* Men and women 18 years of age or older
* Informed consent
* Regularly participating in helping the patient's daily life
* For Physicians :
* Identified as the patient's physician or family physician.
* Informed consent
Exclusion Criteria
* Person who does not speak French easily
* Generally, any person unlikely to cooperate in the study
* Adults under guardianship
* Refusal of relatives and/or general practitioner to participate to the study
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Besançon
Besançon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stéphanie Servagui, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DOSAGE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.